2014
DOI: 10.1016/j.bjhh.2014.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Hemophagocytic lymphohistiocytosis: a case series of a Brazilian institution

Abstract: ObjectiveTo describe the clinical and laboratory presentation of hemophagocytic lymphohistiocytosis in children treated at a referral institution.MethodsA retrospective descriptive study was carried out of seven children diagnosed with hemophagocytic lymphohistiocytosis between 2010 and 2012. The criteria for diagnosis were those proposed by the Histiocyte Society. When indicated, immunochemotherapy was prescribed according to the HLH94 and HLH2004 protocols of the Histiocyte Society.ResultsThe patients’ ages … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 10 publications
(44 reference statements)
0
15
0
1
Order By: Relevance
“…In a vulnerable host, these set off a robust and pathological immune response that ultimately leads to the observed clinical phenotype. Our knowledge of the pathogenesis and clinical course of HLH is in evolution, and much of our understanding derives from the paediatric literature and case reports, with very few larger case series (Majluf-Cruz et al, 1998;Miyahara et al, 2000;Takahashi et al, 2001;Han et al, 2007;Ishii et al, 2007;Machaczka et al, 2011;Park et al, 2012;Nair et al, 2013;Ferreira et al, 2014;Li et al, 2014;Parikh et al, 2014;Rivi ere et al, 2014). Here we describe our experience of diagnosing and treating patients with HLH across 3 large tertiary care centres: Brigham and Women's Hospital, Beth Israel Deaconess Medical Center and Massachusetts General Hospital.…”
Section: Discussionmentioning
confidence: 99%
“…In a vulnerable host, these set off a robust and pathological immune response that ultimately leads to the observed clinical phenotype. Our knowledge of the pathogenesis and clinical course of HLH is in evolution, and much of our understanding derives from the paediatric literature and case reports, with very few larger case series (Majluf-Cruz et al, 1998;Miyahara et al, 2000;Takahashi et al, 2001;Han et al, 2007;Ishii et al, 2007;Machaczka et al, 2011;Park et al, 2012;Nair et al, 2013;Ferreira et al, 2014;Li et al, 2014;Parikh et al, 2014;Rivi ere et al, 2014). Here we describe our experience of diagnosing and treating patients with HLH across 3 large tertiary care centres: Brigham and Women's Hospital, Beth Israel Deaconess Medical Center and Massachusetts General Hospital.…”
Section: Discussionmentioning
confidence: 99%
“…Beta2 microglobulin is a strong and independent prognostic factor for overall survival in lymphoma associated hemophagocytic syndrome [17]. Remission in secondary HLH following treatment of underlying disease has been reported in a Brazilian series [18]. For primary HLH, immunochemotherapy can lead to remission but bone marrow transplant is needed for cure [18].…”
Section: Discussionmentioning
confidence: 99%
“…Remission in secondary HLH following treatment of underlying disease has been reported in a Brazilian series [18]. For primary HLH, immunochemotherapy can lead to remission but bone marrow transplant is needed for cure [18]. …”
Section: Discussionmentioning
confidence: 99%
“…Foram submetidos os dados à análise de variância e comparação entre as médias pelo teste de Scott-Knott, a 5% de significância, e, então, realizadas as análise de regressão polinomial para as diferentes concentrações de manitol, utilizando o programa SISVAR 14 . Além disso, realizou-se a análise de correlação de Spearman (r) para avaliar o grau de associação entre as doses de manitol e a porcentagem de germinação das sementes.…”
Section: Methodsunclassified